Feng Z - Search Results

1

Novel multi‑kinase inhibitor, T03 inhibits Taxol‑resistant breast cancer.

Li Y, Liu C, Tang K, Chen Y, Tian K, Feng Z, Chen J. Li Y, et al. Among authors: feng z. Mol Med Rep. 2018 Feb;17(2):2373-2383. doi: 10.3892/mmr.2017.8179. Epub 2017 Nov 28. Mol Med Rep. 2018. PMID: 29207185 Free PMC article.

2

F84, a quinazoline derivative, exhibits high potent antitumor activity against human gynecologic malignancies.

Li J, Meng Y, Liu Y, Feng ZQ, Chen XG. Li J, et al. Invest New Drugs. 2010 Apr;28(2):132-8. doi: 10.1007/s10637-009-9225-9. Epub 2009 Feb 12. Invest New Drugs. 2010. PMID: 19214386

3

Anti-tumor activity of a novel EGFR tyrosine kinase inhibitor against human NSCLC in vitro and in vivo.

Li J, Li Y, Feng ZQ, Chen XG. Li J, et al. Cancer Lett. 2009 Jul 8;279(2):213-20. doi: 10.1016/j.canlet.2009.01.042. Epub 2009 Mar 18. Cancer Lett. 2009. PMID: 19299077

4

Activity of FB2, a novel dual Abl/Src tyrosine kinase inhibitor, against imatinib-resistant chronic myeloid leukemia in vivo and in vitro.

Liu H, Li H, Feng Z, Tai J, Meng Y, Wang H, Xin H, Zhang S, Zuo M, Zhang Y, Chen X. Liu H, et al. Among authors: feng z. Leuk Lymphoma. 2009 Mar;50(3):437-46. doi: 10.1080/10428190802709438. Leuk Lymphoma. 2009. PMID: 19347730

5

[Design, synthesis and antitumor activity of sorafenib analogues containing 2-picolinylhydrazide moiety].

Qin AF, Li Y, Song HR, Chen XG, Jin XF, Wang K, Zhang LJ, Huo LC, Feng ZQ. Qin AF, et al. Yao Xue Xue Bao. 2012 Dec;47(12):1623-9. Yao Xue Xue Bao. 2012. PMID: 23460968 Chinese.

6

Discovery of novel urea derivatives as dual-target hypoglycemic agents that activate glucokinase and PPARγ.

Li Y, Tian K, Qin A, Zhang L, Huo L, Lei L, Shen Z, Song H, Feng Z. Li Y, et al. Among authors: feng z. Eur J Med Chem. 2014 Apr 9;76:182-92. doi: 10.1016/j.ejmech.2014.02.024. Epub 2014 Feb 11. Eur J Med Chem. 2014. PMID: 24583379

7

[Synthesis and in vitro cytotoxic activities of sorafenib derivatives].

Wang K, Li Y, Zhang LJ, Yang HZ, Chen XG, Feng ZQ. Wang K, et al. Yao Xue Xue Bao. 2014 May;49(5):639-43. Yao Xue Xue Bao. 2014. PMID: 25151734 Chinese.

8

[Anti-tumor activity and mechanism of T03 in vitro and in vivo].

Tang K, Yang HZ, Li Y, Tian K, Li C, Zhou WQ, Niu F, Feng ZQ, Chen XG. Tang K, et al. Yao Xue Xue Bao. 2014 Jun;49(6):861-8. Yao Xue Xue Bao. 2014. PMID: 25212033 Chinese.

9

[Synthesis and biological evaluation of 2-(3-butynoicamidophenyl) benzothiazole derivatives as antitumor agents].

Yin GL, Li Y, Tang K, Jin XF, Chen XG, Li L, Feng ZQ. Yin GL, et al. Yao Xue Xue Bao. 2014 Jun;49(6):888-95. Yao Xue Xue Bao. 2014. PMID: 25212037 Chinese.

10

[Synthesis of novel curcumin mimics and preliminary evaluation for their antitumor activity].

Wang YC, Li YS, Yang HZ, Li Y, Chen XG, Feng ZQ. Wang YC, et al. Yao Xue Xue Bao. 2014 Jul;49(7):1022-8. Yao Xue Xue Bao. 2014. PMID: 25233634 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,256 results

Search Page

Filters